ASH elects three to leadership positions
Click Here to Manage Email Alerts
Three physicians have been elected to serve in leadership roles on ASH’s executive committee.
Their terms will begin after this year’s ASH Annual Meeting and Exposition, which will be held Dec. 9-12 in San Diego.
Robert S. Negrin, MD, will serve a 1-year term as vice president, followed by successive terms as president-elect and president.
Mary M. Horowitz, MD, MS, and H. Leighton Grimes, PhD, will serve 4-year terms as councillors.
“Drs. Negrin, Horowitz and Grimes have demonstrated immense dedication to ASH, its members and the field of hematology. Together, they represent the future of the society and the field,” ASH President Robert A. Brodsky, MD, professor of medicine at Johns Hopkins University School of Medicine, said in a press release. “Under their leadership, the society will be well-positioned to lead our field in education, cutting-edge research, and advocacy on behalf of patients with blood disorders worldwide.”
Negrin is professor of medicine at Stanford University. He is recognized for his research contributions in the areas of hematopoietic cell transplantation, cellular immunology and immune system regulation. He has been an ASH member since 1998, serving as founding editor-in-chief of Blood Advances from 2016 to 2021.
“In this extraordinary time in hematology, I look forward to working with the society to strengthen the hematology workforce, support innovative research, and promote access to existing and emerging therapies for patients with hematologic disorders,” Negrin said. “I am honored to have the opportunity to lead such a highly regarded society and serve the global hematology community.”
Horowitz is deputy director of Medical College of Wisconsin Cancer Center. Her research interests include hematopoietic stem cell transplantation, survivorship and quality of life, as well as the integration of real-world and clinical trial data.
Horowitz has been a member of ASH since 1981, serving as chair of the nominating committee from 2019 to 2022.
Grimes — who will serve as ASH’s first councillor in basic investigative research — is professor in the division of immunobiology at Cincinnati Children’s Hospital Medical Center. His research areas of interest include hematopoiesis, molecular biology and molecular oncology — specifically mouse modeling of hematopoiesis, myelopoiesis and marrow failure syndromes.
Grimes has been an ASH member since 2001, serving on the awards committee, chair of the scientific committee on myeloid biology, and ad hoc member of the scientific committee on bone marrow failure.
Click Here to Manage Email Alerts